NOVOPHARM MARKETING GENERIC RANITIDINE THROUGH AGREEMENT WITH GENPHARM; THREE-WEEK DELAY BRINGS GLAXO $100 MIL. IN ADDITIONAL ZANTAC SALES

Novopharm has begun marketing its generic version of Glaxo Wellcome's Zantac through a commercial agreement with Genpharm. FDA approved Novopharm's ranitidine tablets on July 31.